NCT03433469 Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03431051 The Impact of Workplace Food and Beverage Choices on Health and Wellness Status UNKNOWN Phase NA
NCT03430687 Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma Status WITHDRAWN Phase PHASE1
NCT03430323 Ultra Dual-Energy X-ray Absorptiometry (DXA): Accurate and Precise Quantitative Multi-compartment Body Composition Status COMPLETED Phase N/A
NCT03427476 CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03419130 Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT03418870 Improving Preterm Infant Outcomes With Family Integrated Care and Mobile Technology Status COMPLETED Phase NA
NCT03412760 Hydrops: Diagnosing & Redefining Outcomes With Precision Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT03405662 Impact of Photobiomodulation (PBM) on Biomarkers of Alzheimer's Disease Status COMPLETED Phase NA
NCT03404297 Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya Status COMPLETED Phase NA
NCT03402139 Early Childhood Obesity Programming by Intrauterine Growth Restriction Status RECRUITING Phase N/A
NCT03396952 Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma Status COMPLETED Phase PHASE2
NCT03396926 Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer Status COMPLETED Phase PHASE2
NCT03384771 Predictors of Outcomes in MBSR Participants From Teacher Factors Status COMPLETED Phase N/A